These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 27569031)
1. Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models. Sarisozen C; Dhokai S; Tsikudo EG; Luther E; Rachman IM; Torchilin VP Eur J Pharm Biopharm; 2016 Nov; 108():54-67. PubMed ID: 27569031 [TBL] [Abstract][Full Text] [Related]
2. Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin. Abouzeid AH; Patel NR; Rachman IM; Senn S; Torchilin VP J Drug Target; 2013 Dec; 21(10):994-1000. PubMed ID: 24098980 [TBL] [Abstract][Full Text] [Related]
3. Glucose transporter 1-mediated vascular translocation of nanomedicines enhances accumulation and efficacy in solid tumors. Suzuki K; Miura Y; Mochida Y; Miyazaki T; Toh K; Anraku Y; Melo V; Liu X; Ishii T; Nagano O; Saya H; Cabral H; Kataoka K J Control Release; 2019 May; 301():28-41. PubMed ID: 30844476 [TBL] [Abstract][Full Text] [Related]
4. The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors. Sarisozen C; Abouzeid AH; Torchilin VP Eur J Pharm Biopharm; 2014 Oct; 88(2):539-50. PubMed ID: 25016976 [TBL] [Abstract][Full Text] [Related]
5. Synergistically Improved Anti-tumor Efficacy by Co-delivery Doxorubicin and Curcumin Polymeric Micelles. Wang J; Ma W; Tu P Macromol Biosci; 2015 Sep; 15(9):1252-61. PubMed ID: 25981672 [TBL] [Abstract][Full Text] [Related]
6. Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancer. Scarano W; de Souza P; Stenzel MH Biomater Sci; 2015 Jan; 3(1):163-74. PubMed ID: 26214199 [TBL] [Abstract][Full Text] [Related]
7. Enhanced targeting of 3D pancreatic cancer spheroids by aptamer-conjugated polymeric micelles with deep tumor penetration. Tian L; Pei R; Zhong L; Ji Y; Zhou D; Zhou S Eur J Pharmacol; 2021 Mar; 894():173814. PubMed ID: 33352182 [TBL] [Abstract][Full Text] [Related]
8. Cell microenvironment-controlled antitumor drug releasing-nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy. Guo Y; Zhang Y; Li J; Zhang Y; Lu Y; Jiang X; He X; Ma H; An S; Jiang C ACS Appl Mater Interfaces; 2015 Mar; 7(9):5444-53. PubMed ID: 25686400 [TBL] [Abstract][Full Text] [Related]
9. Transferrin-Modified Vitamin-E/Lipid Based Polymeric Micelles for Improved Tumor Targeting and Anticancer Effect of Curcumin. Muddineti OS; Kumari P; Ghosh B; Biswas S Pharm Res; 2018 Mar; 35(5):97. PubMed ID: 29541866 [TBL] [Abstract][Full Text] [Related]
10. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771 [TBL] [Abstract][Full Text] [Related]
11. Doxorubicin and lapatinib combination nanomedicine for treating resistant breast cancer. Wang H; Li F; Du C; Wang H; Mahato RI; Huang Y Mol Pharm; 2014 Aug; 11(8):2600-11. PubMed ID: 24405470 [TBL] [Abstract][Full Text] [Related]
12. Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model. Perche F; Patel NR; Torchilin VP J Control Release; 2012 Nov; 164(1):95-102. PubMed ID: 22974689 [TBL] [Abstract][Full Text] [Related]
13. Micelle-assisted combination therapies for effective glioblastoma treatment: an in-vitro assessment. Mohanty AK; Mohanta GP Anticancer Drugs; 2015 Mar; 26(3):312-22. PubMed ID: 25462134 [TBL] [Abstract][Full Text] [Related]
14. Transferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells. Abouzeid AH; Patel NR; Sarisozen C; Torchilin VP Pharm Res; 2014 Aug; 31(8):1938-45. PubMed ID: 24522815 [TBL] [Abstract][Full Text] [Related]
15. Polymeric micellar co-delivery of resveratrol and curcumin to mitigate in vitro doxorubicin-induced cardiotoxicity. Carlson LJ; Cote B; Alani AW; Rao DA J Pharm Sci; 2014 Aug; 103(8):2315-22. PubMed ID: 24914015 [TBL] [Abstract][Full Text] [Related]
16. On-demand combinational delivery of curcumin and doxorubicin via a pH-labile micellar nanocarrier. Li H; Li M; Chen C; Fan A; Kong D; Wang Z; Zhao Y Int J Pharm; 2015 Nov; 495(1):572-578. PubMed ID: 26387617 [TBL] [Abstract][Full Text] [Related]
17. Combination of magnetic targeting with synergistic inhibition of NF-κB and glutathione via micellar drug nanomedicine enhances its anti-tumor efficacy. Elhasany KA; Khattab SN; Bekhit AA; Ragab DM; Abdulkader MA; Zaky A; Helmy MW; Ashour HMA; Teleb M; Haiba NS; Elzoghby AO Eur J Pharm Biopharm; 2020 Oct; 155():162-176. PubMed ID: 32818610 [TBL] [Abstract][Full Text] [Related]
18. Co-assembly of doxorubicin and curcumin targeted micelles for synergistic delivery and improving anti-tumor efficacy. Ma W; Guo Q; Li Y; Wang X; Wang J; Tu P Eur J Pharm Biopharm; 2017 Mar; 112():209-223. PubMed ID: 27913127 [TBL] [Abstract][Full Text] [Related]
19. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer. Li C; Ge X; Wang L Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539 [TBL] [Abstract][Full Text] [Related]
20. Multifunctional redox-responsive and CD44 receptor targeting polymer-drug nanomedicine based curcumin and alendronate: synthesis, characterization and in vitro evaluation. Dong X; Zou S; Guo C; Wang K; Zhao F; Fan H; Yin J; Chen D Artif Cells Nanomed Biotechnol; 2018; 46(sup1):168-177. PubMed ID: 29239219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]